A total of 10 chromanone derivatives (1-10), including two new compounds (1 and 2), were isolated from the fruits of Cynanchum thesiodes, and their structures were identified based on UV, IR, MS and NMR spectroscopic data, and comparison with those of reference compounds. The isolated compounds (1-10) were evaluated for their antiangiogenic activity by MTT assay using axitinib as a positive control. As a result, 1, 2, 3 and 9 exhibited important antiangiogenic activity with IC 50 values of 13.8, 11.9, 43.6, and 74.8 μM, respectively.
Cynanchum thesiodes belonging to the Asclepiadaceae family is used as an important folk medicine in many areas of China. It has the functions of clearing heat and reducing fire, inducing saliva and slaking thirst, reducing inflammation and relieving pain in folk for hundreds of years [1] . Previous phytochemical investigations of C. thesiodes showed the presence of triterpenoids [1] , flavonols [2] , steroids and phenolic acids [3] , and amyrin and oleanolic acid [4] . Modern pharmacology revealed that C. thesiodes had a variety of pharmacological activity, such as antiaging [5] , neuroprotective [6] , antioxidant [7] and antiviral [5] activity. Based on previous bioactivities of C. thesiodes, it was found that there had few reports on antiangiogenic activity of C. thesiodes, which prompted us to carry out a bioassay-guided investigation of C. thesiodes. As a result, a total of 10 chromanone derivatives (1-10), including two new compounds (1 and 2), were isolated from the fruits of the EtOAc-soluble fraction of C. thesiodes fruits, and their structures were identified based on UV, IR, MS and NMR spectroscopic data, and comparison with those of reference compounds (Figure 1 ). Moreover, compounds 1-10 were evaluated for their antiangiogenic activity by an MTT assay in vitro using axitinib as a positive control [8] . It was found that 1, 2, 3 and 9 exhibited important antiangiogenic activity. 
16-CH 3 )
. A typical carbonyl carbon was observed at δ C 178.1 (C-5) in the 13 C NMR spectrum ( Table 1 ). All the above fragments were connected by the HMBC correlations of H-3/C-4, H-3/C-17, H-6/C-5, H-6/C-8, H-12/C-1a, H-13/C-11, 22-OCH 3 /C-4; the 2D-NOESY correlations of H-13/15-CH 3 , H-13/16-CH 3 , H-7/20-CH 3 ; and the 1 H-1 H COSY correlations of H-6/H-7, H-12/H-13 ( Figure 2 ). Consequently, 1 was elucidated as shown in Figure 1 .
Compound 2 was isolated as a colorless powder. The molecular formula of 2 was assigned as C 27 260, 300 nm, 2 was also a derivative of chromanone [9] . The 1 H and 13 C NMR spectral data of compound 2 (Table 1) Figure 2 ). Therefore, 2 was determined as depicted in Figure 1 .
In addition, the structures of the known compounds 3-10 were identified by comparison of their spectroscopic data with those reported in literature. They were respectively determined as 6-acetyl-2,2-dimethyl-8-(3-hydroxy-3-methyl-1E-butenyl)-chromanone (3) [10] , 2,2-dimethyl-6-hydroxy-8-(3-hydroxy-3-methyl-1E-butenyl)-chromanone (4) [10] , 5-hydroxy-7-methoxy-2-isopropyl-8-methyl-chromone (5) [11] , 5-hydroxy-7-methoxy-2-isopropylchromone (6) [11] , 5(E)-but-3-enyl-3(E)-propenyl-dihydrofuran-2-one (7) [12] , 5-hydroxy-7-methoxy-2,8-dimethylchromone (8) [11] , 7-dimethylallyloxy-5-hydroxy-3-methylchromone (9) [13] , 3-ethyl-5-methoxy-7-hydroxychromone (10) [13] . The known compounds 3-10 were identified as derivatives of chromanones from this plant for the first time.
Compounds 1-10 were evaluated for their antiangiogenic activity by a 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay using axitinib as a positive control ( Table 2 ). Among them, the IC 50 values of 1 and 2, 13.8 and 11.9 μM, respectively, were lower than that the positive control (14.5 μM). However, 3 and 9 displayed weak effects with IC 50 values of 43.6 and 74.8 μM, respectively. Compounds 4-8 and 10 showed no antiangiogenic activity. 
Experimental

General procedures:
The IR spectra were measured on a Nicolet 5700 FT-IR microscope spectrometer (Shanghai Xiangrun Industry Co. Ltd., Shanghai, China) and UV spectra were recorded with an Australia GBC UV-916 spectrophotometer (GBC Scientific Equipment Pty. Ltd., Braeside, Australia). The 1D and 2D NMR spectra were measured on Bruker-400 using tetramethyl silane (TMS) as internal standard. The HR-ESI-MS data were measured with an Agilent 1100 series LC/MSD ion trap mass spectrometer (Agilent Technologies, California, America). The ESI-MS data were measured on a Q-Trap LC/MS/MS spectrometer (Turbo Ionspray Source). The reversed-phase HPLC was performed on Agilent 1200 series with a DIKMA (4.6 × 250 mm) analytical column packed with C18 (5 μm) (Agilent Technologies, California, America). The column chromatography (CC) was performed on Sephadex LH-20, Toyopearl HW-40C, silica gel (160-200 or 200-300 mesh, Qingdao Marine Chemical Inc., Qingdao, China). TLC was performed on precoated silica gel GF254 plates and the spots were visualized under UV light (254 or 356 nm) or by spraying with 10% H 2 SO4 in 95% EtOH followed by heating [14] .
Plant material:
The dried fruits of C. thesiodes were harvested from Nanyang city of Henan Province of China in September 2017 and were authenticated by Dr. Su Zhang of Wuyang Weisen Biological Medicine Co., Ltd,. A voucher specimen (No. DSG-201709) has been deposited in Nanyang Normal University.
Extraction and isolation:
The dried fruits of C. thesiodes (10.0 kg) were extracted with 90% EtOH (12 L×3) three times at room temperature. The filtrates were concentrated under reduced pressure until elimination of EtOH to obtain a black crude extract (0.95 kg), which was suspended in H 2 O and partitioned successively with Antiangiogenic chromanones from Cynanchum thesiodes Natural Product Communications Vol. 13 (12) 2018 1657 petroleum ether, EtOAc, and n-butanol, successively [14, 15] . As a result, petroleum ether soluble fraction (88.6 g), EtOAc soluble fraction (217.3 g), and n-butanol soluble fraction (294.3 g) were obtained from the above extract, respectively. It was found that the EtOAc soluble fraction showed potential antiangiogenic activity. H 2 O) , repeatedly, yielding 5 (10.5 mg, purity > 97.9% by HPLC), 6 (9.9 mg, purity > 98.0% by HPLC), 7 (11.6 mg, purity > 98.6% by HPLC), 9 (10.5 mg, purity > 97.8% by HPLC) and 10 (12.5 mg, purity > 97.5% by HPLC). In the same way, the sub-fraction C-3 was applied to a silica gel CC (200-300 mesh) eluting with ether/EtOAc (8:1→6:1→4:1) to afford three fractions: C-3a (5.65 g), C-3b (7.55 g), and C-3c (5.02 g). Antiangiogenic assay: Compounds 1-10 were evaluated for their antiangiogenic activity by an MTT assay to determine whether they decreased VEGF-mediated cell proliferation in human umbilical vascular endothelial cells (HUVECs) using axitinib as a positive control [8] . The HUVECs were fostered in 10% fetal bovine serum and Dulbecco modified Eagle medium with 100 μg/mL penicillin/streptomycin in a humidified atmosphere in 5% CO 2 at 37°C, and they were seeded in 96-well plates containing 10 ng/mL vascular endothelial growth factor [14] . Compounds 1-10 were dissolved in dimethyl sulfoxide (DMSO) and diluted with the culture medium to obtain the final 0.2% DMSO. The reagent of MTT was added to cultured cells and incubated for 24 h. After incubation, cell proliferation was measured at a wavelength of 450 nm. The results were calculated by using linear interpolation of inhibition curves for five independent experiments and typically expressed as IC 50 values [16] .
Conclusion:
In this work, two new chromanone derivatives (1 and 2) and eight known ones (3-10) were isolated from C. thesiodes fruits. Among them, 1, 2, 3 and 9 exhibited important antiangiogenic activity with IC 50 values of 13.8, 11.9, 43.6 and 74.8 μM, respectively.
